Hikma Pharma tumbles on softer guidance as buyback fails to soften pill [Yahoo! Finance]
HIKMA PHARMS PLC S/ADR (HKMPY)
NASDAQ:AMEX Investor Relations:
hikma.com/en/investors.html
Company Research
Source: Yahoo! Finance
Hikma Pharmaceuticals PLC shares fell almost 16% to 1,390p after the drugs group delivered results for 2025 in line with forecasts but disappointed with weaker than expected guidance for 2026. Executive chair Said Darwazah will become full-time chief executive for the next two years, with current chief financial officer Khalid Nabilsi becoming deputy chief executive with responsibility for North America and Europe. Group finance chief Areb Kurdi will serve as acting chief financial officer while a search for a permanent CFO is underway. Revenue rose 7% to £3.3 billion, while operating profit fell 11% to £542 million, reflecting margin pressure despite the increase in sales. Injectables revenues rose 7%, in line with guidance of 7-9%. Generics were flat, as guided, while Branded grew 10%, ahead of its 6-7% target. Results were broadly in line with expectations at group level, with revenues, operating profit and adjusted earnings per share matching expectations, sweetened with
Show less
Read more
Impact Snapshot
Event Time:
HKMPY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HKMPY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HKMPY alerts
High impacting HIKMA PHARMS PLC S/ADR news events
Weekly update
A roundup of the hottest topics
HKMPY
News
- Hikma Pharmaceuticals reports FY results [Seeking Alpha]Seeking Alpha
- Hikma Pharmaceuticals PLC (HKMPF) Full Year 2025 Earnings Call Highlights: Strong EBITDA ... [Yahoo! Finance]Yahoo! Finance
- Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Hikma Pharmaceuticals H2 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Hikma Pharmaceuticals gains amid takeover speculation [Seeking Alpha]Seeking Alpha